Improved outcomes with novel agents and auto-SCT for multiple myeloma in African-American patients

被引：2
|
作者：
Saraf, S. L. [1 ]
Patel, P.
Ozer, H.
Peace, D. J.
Quigley, J. G.
Mahmud, N.
Rondelli, D.
机构：
[1] Univ Illinois, Hematol Oncol Sect, Chicago, IL 60680 USA
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷 / 02期
关键词：
STEM-CELL TRANSPLANTATION; STAGING SYSTEM; CHEMOTHERAPY; SURVIVAL;
D O I：
10.1038/bmt.2012.148
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：319 / 320
页数：2
相关论文
共 50 条
  • [41] Auto-SCT for myeloma patients in non-HEPA filtered room: initial experience of a tertiary care center
    Dolai, Tuphan Kanti
    Kumar, Meet
    Mandal, Prakas Kumar
    Saha, Sandeep
    Bagchi, Basab
    Panigrahi, Ashutosh
    De, Rajib
    Dutta, Shyamali
    Bhattacharyya, Maitreyee
    Ghosh, Malay Kumar
    LEUKEMIA & LYMPHOMA, 2013, 54 : 26 - 26
  • [42] Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto-SCT successfully treated with combination therapy
    L Fianchi
    C Colosimo
    A De Luca
    A Pompucci
    P Cattani
    M T Voso
    L M LaRocca
    G Leone
    L Pagano
    Bone Marrow Transplantation, 2010, 45 : 1668 - 1670
  • [43] A case of severe cutaneous, GI and liver GVHD in a patient with multiple myeloma, status-post-second auto-SCT
    Goddard, D. S.
    Ruben, B. S.
    Mathes, E. D.
    Nixon, M.
    Wolf, J.
    Fox, L. P.
    BONE MARROW TRANSPLANTATION, 2010, 45 (02) : 409 - 411
  • [44] Five years of experience and observation with therapy of maintenance with very low dose thalidomide after auto-SCT in multiple myeloma
    Pezzullo, L.
    Rocco, S.
    Bene, L.
    Ferrara, M. G.
    Finizio, O.
    Nunziata, G.
    Martorelli, C.
    Mettivier, L.
    Buonanno, M. T.
    Mettivier, V
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 146 - 147
  • [45] Retraction Note: First-line thalidomide–dexamethasone therapy in preparation for auto-SCT in young patients (<61 years) with symptomatic multiple myeloma
    A Abdelkefi
    L Torjman
    N Ben Romdhane
    S Ladeb
    H El Omri
    T Ben Othman
    M Elloumi
    H Bellaj
    A Lakhal
    R Jeddi
    L Aissaouï
    A Saad
    M Hsaïri
    K Boukef
    K Dellagi
    A Ben Abdeladhim
    Bone Marrow Transplantation, 2009, 43 : 893 - 893
  • [46] Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto-SCT successfully treated with combination therapy
    Fianchi, L.
    Colosimo, C.
    De Luca, A.
    Pompucci, A.
    Cattani, P.
    Voso, M. T.
    LaRocca, L. M.
    Leone, G.
    Pagano, L.
    BONE MARROW TRANSPLANTATION, 2010, 45 (11) : 1668 - 1670
  • [47] The polymorphism IL-1β T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT
    Vangsted, A. J.
    Klausen, T. W.
    Ruminski, W.
    Gimsing, P.
    Andersen, N. F.
    Gang, A. O.
    Abildgaard, N.
    Knudsen, L. M.
    Nielsen, J. L.
    Gregersen, H.
    Vogel, U.
    BONE MARROW TRANSPLANTATION, 2009, 43 (07) : 539 - 545
  • [48] The polymorphism IL-1β T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT
    A J Vangsted
    T W Klausen
    W Ruminski
    P Gimsing
    N F Andersen
    A O Gang
    N Abildgaard
    L M Knudsen
    J L Nielsen
    H Gregersen
    U Vogel
    Bone Marrow Transplantation, 2009, 43 : 539 - 545
  • [49] Improved survival of older patients with multiple myeloma in the era of novel agents
    Mey, Ulrich J. M.
    Leitner, Christoph
    Driessen, Christoph
    Cathomas, Richard
    Klingbiel, Dirk
    Hitz, Felicitas
    HEMATOLOGICAL ONCOLOGY, 2016, 34 (04) : 217 - 223
  • [50] Five years of experience and observation with therapy of maintenance with very low-dose thalidomide after auto-SCT in multiple myeloma
    Pezzullo, L.
    Rocco, S.
    Finizio, O.
    Ferrara, M. G.
    Bene, L.
    Mettivier, L.
    Nunziata, G.
    De Rosa, C.
    Mettivier, V.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S441 - S442
12345